共 50 条
- [41] Assessment of the real-world effectiveness of upadacitinib in patients with moderate-severe ulcerative colitis in a global real-world setting JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1261 - i1263
- [43] Safety and Effectiveness of Tofacitinib in Ulcerative Colitis: Real-world Data from TOFA-UC, a SN-IBD Study JOURNAL OF CROHNS & COLITIS, 2023, 17 : 697 - 697
- [45] Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States Advances in Therapy, 2023, 40 : 4321 - 4338
- [47] Safety of tofacitinib and upadacitinib compared to other advanced therapies in ulcerative colitis: a large real-world comparison JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1996 - i1996
- [50] Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis (UC): evidence from a systematic literature review (SLR) JOURNAL OF CROHNS & COLITIS, 2023, 17 : 739 - 740